ES2100941T3 - Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias. - Google Patents

Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias.

Info

Publication number
ES2100941T3
ES2100941T3 ES91900304T ES91900304T ES2100941T3 ES 2100941 T3 ES2100941 T3 ES 2100941T3 ES 91900304 T ES91900304 T ES 91900304T ES 91900304 T ES91900304 T ES 91900304T ES 2100941 T3 ES2100941 T3 ES 2100941T3
Authority
ES
Spain
Prior art keywords
treatment
cromakalim
hyperreactivity
brl
respiratory tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900304T
Other languages
English (en)
Spanish (es)
Inventor
Derek Richard Buckle
John Frank Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2100941T3 publication Critical patent/ES2100941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES91900304T 1989-12-11 1990-12-11 Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias. Expired - Lifetime ES2100941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898927980A GB8927980D0 (en) 1989-12-11 1989-12-11 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2100941T3 true ES2100941T3 (es) 1997-07-01

Family

ID=10667773

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900304T Expired - Lifetime ES2100941T3 (es) 1989-12-11 1990-12-11 Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias.

Country Status (10)

Country Link
EP (1) EP0471040B1 (de)
AT (1) ATE149832T1 (de)
AU (1) AU7994891A (de)
DE (1) DE69030181T2 (de)
DK (1) DK0471040T3 (de)
ES (1) ES2100941T3 (de)
GB (1) GB8927980D0 (de)
GR (1) GR3023250T3 (de)
IE (1) IE904460A1 (de)
WO (1) WO1991008741A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9124754D0 (en) * 1991-11-21 1992-01-15 Smithkline Beecham Plc Pharmaceuticals
US5646156A (en) * 1994-04-25 1997-07-08 Merck & Co., Inc. Inhibition of eosinophil activation through A3 adenosine receptor antagonism
WO2015117024A1 (en) 2014-01-31 2015-08-06 Mayo Foundation For Medical Education And Research Novel therapeutics for the treatment of glaucoma
AU2020403144A1 (en) 2019-12-12 2022-07-14 Mayo Foundation For Medical Education And Research Controlled-delivery cromakalim prodrugs

Also Published As

Publication number Publication date
IE904460A1 (en) 1991-06-19
EP0471040B1 (de) 1997-03-12
DK0471040T3 (da) 1997-04-01
WO1991008741A1 (en) 1991-06-27
DE69030181T2 (de) 1997-07-17
ATE149832T1 (de) 1997-03-15
GR3023250T3 (en) 1997-07-30
EP0471040A1 (de) 1992-02-19
GB8927980D0 (en) 1990-02-14
DE69030181D1 (de) 1997-04-17
AU7994891A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
AR003426A1 (es) Derivados de rapamicina y procedimiento para prepararlos, composiciones farmacéuticas formuladas con dichos derivados y equipos(kits) que incluyen dichos derivados para tratar infecciones,estados inflamatorios o tratamientos inmunosupresores.
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
ES2103966T3 (es) Uso de una timosina en el tratamiento de hepatitis c.
BR9605111A (pt) Formulação de dosagem farmacêutica oral processo para a manufatura de uma formulação de dosagem fixa método para o tratamento de distúrbios com infecções por helicobacter pylori em mamiferos e no ser humano e uso de uma formulação de dosagem
BR9509498A (pt) Agente aglutinante uso do mesmo composição farmacêutica e processo para tratamento de uma doença inflamatória autoimune ou uma doença alérgica
MX9204078A (es) Metodo y composicion para la prevencion de la enfermedad de lyme.
ES2057568T3 (es) Metodos para tratar la ansiedad con ligandos de receptores sigma.
ES2055406T3 (es) Composicion para el tratamiento de la inflamacion.
MX9205127A (es) Una composicion farmaceutica y un metodo para usar una combinacion de un agente uricosurico y un antagonista eaa.
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
BR9100046A (pt) Derivados de azaoxindole,composicao farmaceutica e processo para o tratamento de mamiferos
TR199900505T2 (de)
ES499227A0 (es) Procedimiento para la determinacion de antigenos carcinoem- brionicos en el plasma humano
KR890701099A (ko) 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질
ES2041845T3 (es) Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.
ATE103779T1 (de) Brausekomponente und verfahren zu ihrer herstellung.
NO984760D0 (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
BR9612234A (pt) Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma
DK0471040T3 (da) Anvendelse af cromakalim/BRL 38227 til behandling af hyperreaktivitet i luftveje
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
NO912942L (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
EP0345948A3 (de) Verwendung von 5-HT1A Agonisten zur Herstellung eines Arzneimittels, das gegen ischämische Verletzungen Schützt

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 471040

Country of ref document: ES